GSK plc (GLAXF)
OTCMKTS · Delayed Price · Currency is USD
27.23
0.00 (0.00%)
Mar 9, 2026, 9:30 AM EST
GSK plc Employees
GSK plc had 66,841 employees as of December 31, 2025. The number of employees decreased by 1,788 or -2.61% compared to the previous year.
Employees
66,841
Change (1Y)
-1,788
Growth (1Y)
-2.61%
Revenue / Employee
$657,775
Profits / Employee
$115,096
Market Cap
111.26B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 66,841 | -1,788 | -2.61% |
| Dec 31, 2024 | 68,629 | -1,583 | -2.25% |
| Dec 31, 2023 | 70,212 | 812 | 1.17% |
| Dec 31, 2022 | 69,400 | -20,696 | -22.97% |
| Dec 31, 2021 | 90,096 | -3,970 | -4.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Glass House Brands | 374 |
| Silence Therapeutics | 116 |
| Vaxart | 105 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Tian'an Technology Group | 8 |
GSK plc News
- 16 hours ago - FDA Approves GSK's Wellcovorin for Cerebral Folate Deficiency - GuruFocus
- 18 hours ago - FDA Approves Drug Trump Touted for Autism to Treat Other Neurological Disorder - WSJ
- 18 hours ago - FDA Approves Leucovorin—But Not For Autism, Even After Trump Admin Officials Touted Drug Last Year - Forbes
- 20 hours ago - US FDA approves leucovorin for ultra- rare genetic disorder causing autism-like symptoms - Reuters
- 20 hours ago - FDA approves leucovorin as first drug for rare genetic disorder, after touting it as autism treatment - CNBC
- 22 hours ago - Pipeline of new drugs to fight superbugs is ‘worryingly thin’, experts warn - The Guardian
- 1 day ago - Former GlaxoSmithKline HQ in west London to be transformed into 1,500 new homes - Evening Standard
- 2 days ago - GSK Sells Rights to Drug Candidate to Alfasigma for Up to $690 Million - WSJ